candesartan cilexetil has been researched along with Cardiac Output, Low in 1 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Cardiac Output, Low: A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
Excerpt | Relevance | Reference |
---|---|---|
"A Medline literature search was undertaken to identify randomised, controlled trials that examined the efficacy and cardiovascular outcomes associated with candesartan cilexetil in hypertension and chronic heart failure (CHF)." | 8.84 | Candesartan cilexetil--a review of effects on cardiovascular complications in hypertension and chronic heart failure. ( Meredith, PA, 2007) |
"A Medline literature search was undertaken to identify randomised, controlled trials that examined the efficacy and cardiovascular outcomes associated with candesartan cilexetil in hypertension and chronic heart failure (CHF)." | 4.84 | Candesartan cilexetil--a review of effects on cardiovascular complications in hypertension and chronic heart failure. ( Meredith, PA, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Meredith, PA | 1 |
1 review available for candesartan cilexetil and Cardiac Output, Low
Article | Year |
---|---|
Candesartan cilexetil--a review of effects on cardiovascular complications in hypertension and chronic heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds | 2007 |